Literature DB >> 8085557

Biphasic and monophasic sarcomatoid carcinomas of the lung. A reappraisal of 'carcinosarcomas' and 'spindle-cell carcinomas'.

O Nappi1, S D Glasner, P E Swanson, M R Wick.   

Abstract

To address the premise that pulmonary "carcinosarcomas" and spindle-cell carcinomas are part of a single clinicopathologic continuum, the authors studied 21 examples of such lesions as defined by World Health Organization criteria. Two biphasic tumors demonstrated an admixture of overt carcinoma with other foci showing partial rhabdomyogenic differentiation; 15 others were histologically similar but lacked "heterologous" sarcoma-like elements; and four lesions were monophasic spindle-cell sarcomatoid carcinomas. One of the latter also contained rhabdomyosarcoma-like areas by light microscopy. Sarcomatoid components were reactive for keratin and/or epithelial membrane antigen (EMA) in 18/21 cases. In addition, desmin and muscle-specific actin were co-detected in the same spindle cells that were keratin-positive in 4 tumors, 3 of which were those with partially myogenic histologic features. Vimentin was present in keratin- or EMA-reactive sarcomatoid cells in 12 neoplasms, and all cases were labeled with an antibody to collagen type IV. Survival was poor in this group of patients; only 1 was alive at last contact. These data support the contention that "carcinosarcoma" of the lung is part of a spectrum with "spindle-cell carcinoma." It is proposed that the terms "biphasic sarcomatoid carcinoma" and "monophasic sarcomatoid carcinoma" are more apt descriptors for such tumors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8085557     DOI: 10.1093/ajcp/102.3.331

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  16 in total

1.  Unusual sarcomatoid neoplasm of the lung suggesting a myofibrosarcoma.

Authors:  Lars Morawietz; Cornelius Kuhnen; Detlef Katenkamp; Philipp Le Coutre; Axel Ladhoff; Iver Petersen
Journal:  Virchows Arch       Date:  2005-09-13       Impact factor: 4.064

Review 2.  The pivotal role of pathology in the management of lung cancer.

Authors:  Morgan R Davidson; Adi F Gazdar; Belinda E Clarke
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

3.  Expression of CD99 in pleomorphic carcinomas of the lung.

Authors:  Seong-Ho Yoo; Jungho Han; Tae Jin Kim; Doo Hyun Chung
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

4.  Carcinosarcoma of the bile duct: a case report and review of literature.

Authors:  Ser Yee Lee; Jinru Shia; T Peter Kingham; William R Jarnagin
Journal:  Hepatobiliary Surg Nutr       Date:  2016-02       Impact factor: 7.293

5.  Molecular characterization of pulmonary sarcomatoid carcinoma: analysis of 33 cases.

Authors:  Simone Bsp Terra; Jin S Jang; Lintao Bi; Benjamin R Kipp; Jin Jen; Eunhee S Yi; Jennifer M Boland
Journal:  Mod Pathol       Date:  2016-05-13       Impact factor: 7.842

Review 6.  Carcinosarcoma of the duodenum: Report of a case.

Authors:  Hiroki Sunagawa; Susumu Inamine; Mikiko Watanabe; Kouji Kawakami; Tetsuo Toyama; Hisamitsu Zaha; Toshimi Yonaha; Morio Ohta; Naoto Oshiro; Masanori Takeshima; Hisataka Uchima
Journal:  Surg Today       Date:  2009-09-27       Impact factor: 2.549

Review 7.  Primary osteosarcoma of the lung: a case report and review of the literature.

Authors:  Rui Niimi; Akihiko Matsumine; Katsuyuki Kusuzaki; Yasuhiro Inada; Yuya Kato; Masayuki Maeda; Atsumasa Uchida
Journal:  Med Oncol       Date:  2007-10-25       Impact factor: 3.064

8.  Predominant sarcomatoid carcinoma of the lung concurrent with jejunal metastasis and leukocytosis.

Authors:  Jun Jia; Jun Ren; Jin Gu; Lijun Di; Guohong Song
Journal:  Rare Tumors       Date:  2010-09-30

9.  Cutaneous carcinosarcoma with metastasis to the parotid gland.

Authors:  Tze Ling Loh; Jeanne Tomlinson; Ronald Chin; Guy D Eslick
Journal:  Case Rep Otolaryngol       Date:  2014-09-25

Review 10.  An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin.

Authors:  Andrew M Bellizzi
Journal:  Adv Anat Pathol       Date:  2020-05       Impact factor: 4.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.